General Information of the Compound
Compound ID
CP0064283
Compound Name
Balversa
    Show/Hide
Synonyms
1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-
1346242-81-6
890E37NHMV
AC-30222
AKOS030526429
AS-35040
CHEMBL3545376
CS-4988
D10927
DB12147
Erdafitinib
Erdafitinib (USAN/INN)
Erdafitinib [USAN:INN]
GTPL9039
HY-18708
JNJ-42756493 (Erdafitinib)
KB-333716
MolPort-044-560-398
N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quino
SCHEMBL2583760
UNII-890E37NHMV
ZINC168520308
compound 4 [WO2011135376]
s8401
    Show/Hide
Structure
Formula
C25H30N6O2
Molecular Weight
446.555
Canonical SMILES
COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1
    Show/Hide
InChI
InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
    Show/Hide
InChIKey
OLAHOMJCDNXHFI-UHFFFAOYSA-N
CAS
1346242-81-6
Physicochemical Property
logP
4.1836
Rotatable Bonds
9
Heavy Atom Count
33
Polar Areas
77.33
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 67462786
ChEMBL ID
CHEMBL3545376
DrugBank ID
DB12147
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  2
1
IC50 = 83.18 nM
   TI
   LI
   LO
   TS
2
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1.2 nM
2 IC50 = 1.53 nM
3 IC50 = 1.862 nM
4 IC50 < 10 nM
5 IC50 = 1658 nM
Protein ID: PT01411, Fibroblast growth factor receptor 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  2
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
2
IC50 >= 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.42 nM
2 IC50 = 1.62 nM
3 IC50 = 2.5 nM
4 IC50 = 3 nM
5 IC50 = 3.802 nM
6 IC50 < 10 nM
7 IC50 = 112.6 nM
Protein ID: PT01343, Fibroblast growth factor receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 3.8 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2 nM
2 IC50 = 5.7 nM
3 IC50 = 6.607 nM
4 IC50 < 10 nM
5 IC50 = 18.7 nM
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  2
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
2
IC50 >= 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  2
1
IC50 = 3311.31 nM
   TI
   LI
   LO
   TS
2
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 < 10 nM
2 IC50 = 36.8 nM
3 IC50 = 37 nM
4 IC50 = 47.86 nM
Clinical Information about the Compound
Drug 1 ( Erdafitinib )
Drug Name Erdafitinib
Company Janssen Research & Development Raritan, NJ
Indication
Bladder cancer
Approved
Urothelial carcinoma
Phase 2
Solid tumour/cancer
Phase 2
Lymphoma
Phase 1/2